loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Fasedienol

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Fasedienol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,120Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vistagen Initiates PALISADE-4 Phase 3 Study Of Fasedienol
    Vistagen Initiates PALISADE-4 Phase 3 Study Of Fasedienol

    23 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240923438804/en

    BUSINESSWIRE
    23 Sep 2024
    Share Share
    Vistagen Initiates Ph3 Study of Fasedienol for the Social Anxiety Disorder
    Vistagen Initiates Ph3 Study of Fasedienol for the Social Anxiety Disorder

    01 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240401402849/en

    BUSINESSWIRE
    01 Apr 2024
    Share Share
    Vistagen Reports Positive Results from Phase 3 Trial of Fasedienol Nasal Spray
    Vistagen Reports Positive Results from Phase 3 Trial of Fasedienol Nasal Spray

    10 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/affamed-therapeutics-announces-partner-vistagen-reports-positive-top-line-results-from-phase-3-palisade-2-trial-of-fasedienol-ph94b-nasal-spray-in-social-anxiety-disorder-301897671.html

    PR NEWSWIRE
    10 Aug 2023
    Share Share
    Vistagen stock soars 1,272% on social anxiety spray data
    Vistagen stock soars 1,272% on social anxiety spray data

    08 Aug 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vistagens-stock-skyrockets-1272-after-social-anxiety-nasal-spray-hits-phase-3-trial-goals

    Gabrielle Masson FIERCE BIOTECH
    08 Aug 2023
    Share Share
    Vistagen Announces Positive Results from Phase 3 Trial of Fasedienol
    Vistagen Announces Positive Results from Phase 3 Trial of Fasedienol

    07 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230807764660/en

    BUSINESSWIRE
    07 Aug 2023
    Share Share
    Vistagen Presents Fasedienol (PH94B) Safety and Exploratory Efficacy Data
    Vistagen Presents Fasedienol (PH94B) Safety and Exploratory Efficacy Data

    01 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230601005454/en

    BUSINESSWIRE
    01 Jun 2023
    Share Share